The study showed that high SLCO1B3 expression was associated with poor tumor differentiation, advanced disease stage, tumor invasion, lymph node metastasis, and poor OS. The gene discussed is SLCO1B3; the disease is metastatic malignant neoplasm in the lymph nodes.